4.4 Review

Understanding perspectives of signalling mechanisms regulating PEBP1 function

Journal

CELL BIOCHEMISTRY AND FUNCTION
Volume 34, Issue 6, Pages 394-403

Publisher

WILEY
DOI: 10.1002/cbf.3198

Keywords

PEBP1; RKIP; cancer; MAPK; neurodegeneration

Funding

  1. SERB, New Delhi, India [YSS/2015/000110]
  2. UGC MRP grant [39-240/2010 (SR)]
  3. UGC, India

Ask authors/readers for more resources

Phosphatidylethanolamine-binding protein 1 (PEBP1), also known as Raf kinase inhibitor protein, belongs to PEBP family of proteins. It is known to interact with many proteins that are mainly involved in pathways that monitor cell proliferation and differentiation. PEBP1 in many cells interacts with several pathways, namely MAPK, GRK2, NF-kappa B, etc. that keeps the cell proliferation and differentiation in check. This protein is expressed by many cells in humans, including neurons where it is predominantly involved in production of choline acetyltransferase. Deregulated PEBP1 is known to cause cancer, diabetic nephropathy and neurodegenerative diseases like Alzheimer's and dementia. Recent research led to the discovery of many drugs that mainly target the interaction of PEBP1 with its partners. These compounds are known to bind PEBP1 in its conserved domain which abrogate its association with interacting partners in several different pathways. We outline here the latest developments in understanding of PEBP1 function in maintaining cell integrity. Copyright (C) 2016 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available